home / stock / prn:cc / prn:cc news

PRN:CC News and Press, Profound Medical Corp. From 05/09/24

Stock Information
Company Name: Profound Medical Corp.
Stock Symbol: PRN:CC
Market: TSXC
Website: profoundmedical.com
Menu
PRN:CC PRN:CC Quote PRN:CC Short PRN:CC News PRN:CC Articles PRN:CC Message Board
Get PRN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PRN:CC - Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, tod...
PRN:CC - Expected Canadian Company Earnings on Thursday, May 9th, 2024

Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...

PRN:CC - Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum

— So far this year alone, 25 TULSA-related scientific research presentations have been delivered at major medical meetings around the world — — Of those, eight (8) presentations were from leading urologists at AUA 2024 — — Clinical ...

PRN:CC - Profound Medical to Release First Quarter 2024 Financial Results on May 9 - Conference Call to Follow

TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, w...
PRN:CC - Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...

PRN:CC - Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript

2024-03-07 23:35:04 ET Profound Medical Corp. (PROF) Q4 2023 Earnings Conference Call March 07, 2024 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Arun Menawat – Chief Executive Officer Rashed Dewan – Chief Financial Off...

PRN:CC - Profound Medical GAAP EPS of $0.42 beats by $0.74, revenue of $2M beats by $0.06M

2024-03-07 17:14:10 ET More on Profound Medical Profound Medical lays out Q4 and FY 2024 preliminary numbers Profound Medical sells 2.67M shares at $7.50 in public offering Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for P...
PRN:CC - Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...

PRN:CC - Expected Canadian Company Earnings on Thursday, March 7th, 2024

Taseko Mines Limited (TKO:CA) is expected to report $0.09 for Q4 2023 Purepoint Uranium Group Inc. (PTU:CA) is expected to report for quarter end 2023-12-31 Perpetual Energy Inc. (PMT:CA) is expected to report $-0.02 for Q4 2023 Park Lawn Corporation (PLC:CA) is expected to report $0....

PRN:CC - Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...
Previous 10 Next 10